scholarly article | Q13442814 |
P2093 | author name string | Eider M Arenaza-Urquijo | |
Marc Suárez-Calvet | |||
Juan Domingo Gispert | |||
Oriol Grau-Rivera | |||
Carolina Minguillon | |||
José Luis Molinuevo | |||
Gonzalo Sánchez-Benavides | |||
Marta Crous-Bou | |||
ALFA Study | |||
Gemma Salvadó | |||
Marta Milà-Alomà | |||
Aida Niñerola-Baizán | |||
Andrés Perissinotti | |||
José María González-de-Echávarri | |||
P2860 | cites work | The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment | Q90611885 |
Subjective Cognitive Decline May Be a Stronger Predictor of Incident Dementia in Women than in Men | Q92603418 | ||
The characterisation of subjective cognitive decline | Q92772452 | ||
The relationship between domain-specific subjective cognitive decline and Alzheimer's pathology in normal elderly adults | Q92811542 | ||
Clinical and biomarker changes in dominantly inherited Alzheimer's disease | Q29619940 | ||
Subjective cognitive decline: self and informant comparisons | Q30421568 | ||
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. | Q31063014 | ||
The preclinical Alzheimer cognitive composite: measuring amyloid-related decline | Q34422469 | ||
The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. | Q34989647 | ||
Inclusion of an informant yields strong associations between cognitive complaint and longitudinal cognitive outcomes in non-demented elders | Q35041971 | ||
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease | Q35049917 | ||
The Cognitive Change in Women study (CCW): informant ratings of cognitive change but not self-ratings are associated with neuropsychological performance over 3 years | Q35563760 | ||
Self-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease | Q35611460 | ||
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis | Q35800785 | ||
Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly | Q35850701 | ||
Predicting Alzheimer's disease: neuropsychological tests, self-reports, and informant reports of cognitive difficulties | Q36034307 | ||
Outcomes of stable and unstable patterns of subjective cognitive decline - results from the Leipzig Longitudinal Study of the Aged (LEILA75+). | Q36183046 | ||
Subjective cognitive complaints and amyloid burden in cognitively normal older individuals | Q36322792 | ||
Indicators of amyloid burden in a population-based study of cognitively normal elderly | Q36330933 | ||
Qualitative and quantitative assessment of self-reported cognitive difficulties in nondemented elders: Association with medical help seeking, cognitive deficits, and β-amyloid imaging. | Q37544208 | ||
Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals | Q37732868 | ||
Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis | Q38248954 | ||
Differential Risk of Incident Alzheimer's Disease Dementia in Stable Versus Unstable Patterns of Subjective Cognitive Decline | Q38377766 | ||
Subjective Cognitive Decline in Preclinical Alzheimer's Disease | Q38686409 | ||
The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment | Q40410694 | ||
The value of informant versus individual's complaints of memory impairment in early dementia | Q40735083 | ||
The ALFA project: A research platform to identify early pathophysiological features of Alzheimer's disease | Q42689647 | ||
Risk factors for amyloid positivity in older people reporting significant memory concern | Q47584391 | ||
Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden | Q47607239 | ||
The Subjective Cognitive Decline Questionnaire (SCD-Q): a validation study | Q47904676 | ||
Predicting Cognitive, Functional, and Diagnostic Change over 4 Years Using Baseline Subjective Cognitive Complaints in the Sydney Memory and Ageing Study. | Q48440481 | ||
Characteristics of help-seeking behaviour in subjects with subjective memory complaints at a memory clinic: a case-control study. | Q49055455 | ||
Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting. | Q49903569 | ||
Informants' Perception of Subjective Cognitive Decline Helps to Discriminate Preclinical Alzheimer's Disease from Normal Aging. | Q50560838 | ||
Hippocampal Subfield Volumetry and 3D Surface Mapping in Subjective Cognitive Decline. | Q50706730 | ||
Gender differences in the prodromal signs of dementia: memory complaint and IADL-restriction. a prospective population-based cohort. | Q50795694 | ||
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. | Q52589491 | ||
The Rationale Behind the New Alzheimer's Disease Conceptualization: Lessons Learned During the Last Decades. | Q52644606 | ||
Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples | Q61446706 | ||
Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers | Q64064005 | ||
Odor Identification Ability Predicts PET Amyloid Status and Memory Decline in Older Adults | Q88256197 | ||
Alzheimer's disease: The right drug, the right time | Q90462536 | ||
Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia | Q90568308 | ||
P433 | issue | 1 | |
P304 | page(s) | e12127 | |
P577 | publication date | 2020-11-11 | |
P1433 | published in | Alzheimer's & dementia (Amsterdam, Netherlands) | Q27726390 |
P1476 | title | Quantitative informant- and self-reports of subjective cognitive decline predict amyloid beta PET outcomes in cognitively unimpaired individuals independently of age and APOE ε4 | |
P478 | volume | 12 |
Search more.